CRISPR Therapeutics AG - Common Shares (NQ:CRSP)
Price and Volume
Detailed Quote| Volume | 2,326 |
| Open | 56.71 |
| Bid (Size) | 56.38 (100) |
| Ask (Size) | 56.67 (200) |
| Prev. Close | 56.71 |
| Today's Range | 56.71 - 56.71 |
| 52wk Range | 30.04 - 78.48 |
| Shares Outstanding | 78,935,098 |
| Dividend Yield | N/A |
Top News
More News
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
December 24, 2025
Via PredictStreet
Topics
Economy
Performance
| YTD |
+36.9%
|
+36.9%
|
| 1 Month |
+5.9%
|
+5.9%
|
| 3 Month |
-6.0%
|
-6.0%
|
| 6 Month |
+21.4%
|
+21.4%
|
| 1 Year |
+38.1%
|
+38.1%
|
More News
Read More
Is CRISPR Therapeutics Stock Yesterday's News? ↗
December 24, 2025
Via The Motley Fool
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
December 23, 2025
Via The Motley Fool
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
December 19, 2025
Via The Motley Fool
2 Growth Stocks to Invest $1,000 in Right Now ↗
December 18, 2025
Via The Motley Fool
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
December 16, 2025
From USA News Group
Via GlobeNewswire
2 Monster Stocks in the Making to Buy and Hold ↗
December 16, 2025
Via The Motley Fool
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗
December 15, 2025
Via The Motley Fool
Topics
Artificial Intelligence
2 Healthcare Stocks to Buy Ahead of the New Year ↗
December 12, 2025
Via The Motley Fool
2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗
December 07, 2025
Via The Motley Fool
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
November 30, 2025
Via The Motley Fool
Topics
ETFs
The Best Stocks to Buy With $1,000 Right Now ↗
November 29, 2025
Via The Motley Fool
3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
November 21, 2025
Via The Motley Fool
1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗
November 17, 2025
Via The Motley Fool
Via The Motley Fool
Topics
Regulatory Compliance
Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
November 10, 2025
Topics
Death
Topics
Death
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 56.71
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 12/24/25 01:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.48B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>